MK-0626, a dipeptidyl peptidase-4 inhibitor, improves neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression - Shih, C M; Chen, Y H; Lin, Y W (Curr Med Chem, 2014)
et al.